Arca
Skip to content
Tools
Tools

PA: Polymerase acidic protein

Protein in Influenza A virus (A/Puerto Rico/8/1934(H1N1)) that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 1
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on PA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved1

  • Baloxavir marboxil

Phase 30

    Phase 21

    • Baloxavir

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      Baloxavir marboxilApprovedRocheSmall moleculeInhibitorPolymerase acidic protein inhibitor9
      BaloxavirPhase 2RocheSmall moleculeInhibitorPolymerase acidic protein inhibitor11

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 10 in all, from ClinicalTrials.gov.
      A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese ParticipantsBaloxavir marboxil, BaloxavirPhase 3RecruitingHoffmann-La RocheSep 18, 2026
      Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPDBaloxavir marboxil, Baloxavir—Not yet recruitingTianjin Medical UniversityFeb 6, 2026
      Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)BaloxavirPhase 3RecruitingUnity Health TorontoJan 2, 2026
      Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based SettingBaloxavir marboxil, BaloxavirNot applicableNot yet recruitingCapital Medical UniversityJan 7, 2025
      A/Texas Flu ChallengeBaloxavirPhase 1RecruitingEmory UniversityDec 31, 2024
      Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)Baloxavir marboxil, BaloxavirPhase 3RecruitingDre Pauline VetterOct 22, 2024
      A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsBaloxavir marboxil, BaloxavirPhase 3RecruitingHoffmann-La RocheOct 23, 2023
      A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaBaloxavir marboxil, BaloxavirPhase 2RecruitingUniversity of OxfordDec 13, 2022
      Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsBaloxavir marboxilPhase 2RecruitingM.D. Anderson Cancer CenterJan 15, 2021
      Randomised Evaluation of COVID-19 TherapyBaloxavir marboxilPhase 3RecruitingUniversity of OxfordMay 11, 2020

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1169598, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.